InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（2 笔）
内部人交易记录
高级管理人员已披露买入
1
已披露卖出
2
T+90 胜率
0%
T+90 平均收益
-2.8%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Discover the complete record of transactions filed by Frohlich Tom, 副总经理. Director active across 2 companies, notably Chinook Therapeutics, INC.. Aggregated, 14 disclosures have been recorded. Split: 1 buy · 2 sells. Total volume traded: €344k. History available since 24 September 2021. The latest transaction was disclosed on 12 February 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Frohlich Tom
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报14 总计
78,750 股0Common StockSEC:0001193125-26-052054:0
6,000 股@ US$7.40100.0% 占其流量Common StockSEC:0000950170-25-074496:0
标准退出：2025年8月14日 (T+90)
150,777 股Common StockSEC:0001209191-23-045418:0
6,803 股Common StockSEC:0001209191-23-009769:0
8,333 股Common StockSEC:0001209191-23-006375:0
10,000 股@ US$0.420.6% 占其流量Common StockSEC:0001209191-22-061442:0
10,000 股@ US$0.420.7% 占其流量Common StockSEC:0001209191-22-056210:0
13,582 股Common StockSEC:0001209191-22-053304:0
6,801 股Common StockSEC:0001209191-22-009560:0
6,230 股@ US$15.4825.6% 占其流量Common StockSEC:0001209191-21-064364:0
15,000 股@ US$0.421.7% 占其流量Common StockSEC:0001209191-21-063790:0
13,580 股Common StockSEC:0001209191-21-060114:0
20,000 股@ US$0.422.2% 占其流量Common StockSEC:0001209191-21-057937:0
20,000 股@ US$13.0068.0% 占其流量Common StockSEC:0001209191-21-057713:0
14 条申报中的 14 条
About Frohlich Tom
Frohlich Tom is Directeur Général Adjoint, Responsable des Opérations. He has 14 filings in total, and across the sampled recent filings from 2021-09-24 to 2026-02-13, the reported volumes are 39669 in buys and 304630 in sells, with a modal transaction nature of Levée d'options. The companies mentioned are Chinook Therapeutics, INC. and Jade Biosciences, Inc.
